S
Shan Du
Publications - 5
Citations - 41
Shan Du is an academic researcher. The author has contributed to research in topics: Chemistry & Medicine. The author has an hindex of 1, co-authored 1 publications receiving 16 citations.
Papers
More filters
Journal ArticleDOI
Sensitive Determination of Cyanide in Cigarette Smoke by Capillary GC with a MicroECD
TL;DR: In this paper, a sensitive method using capillary gas chromatography coupled with a micro electron capture detector (μECD) has been developed for the determination of cyanide in cigarette smoke, based upon the conversion of cyanides to cyanogen chloride by chloramine-T.
Journal ArticleDOI
Oridonin Inhibits SARS‐CoV‐2 by Targeting Its 3C‐Like Protease
Baisen Zhong,Weiyu Peng,Shan Du,Bingyi Chen,Yajuan Feng,Xinfeng Hu,Qingying Lai,Shujie Liu,Zhong-Wei Zhou,Pengfei Wang,Yan Liang Xueqiong Wu,Feng Gao,Huihao Zhou,Litao Sun +13 more
TL;DR: It is identified that Oridonin binds at the 3CLpro catalytic site by forming a CS covalent bond, which is confirmed by mass spectrometry and kinetic study, blocking substrate binding through a nonpeptidomimetic covalents binding mode.
Journal ArticleDOI
SUFU suppresses ferroptosis sensitivity in breast cancer cells via Hippo/YAP pathway
Kun Fang,Shan Du,Dachuan Shen,Zhipeng Xiong,Ke Jiang,Dapeng Liang,Jianxin Wang,Huizhe Xu,Lulu Hu,Xingyue Zhai,Yuting Jiang,Zhiyu Xia,Chunrui Xie,Dingli Jin,Wei Chen,Songshu Meng,Yifei Wang +16 more
TL;DR: In this paper , the Suppressor of fused homolog (SUFU), a critical component in Hedgehog signaling, regulates ferroptosis sensitivity of breast cancer cells, and SUFU depletion promoted the activation of Yes-associated protein (YAP), thereby increasing the expression of ACSL4.
Journal ArticleDOI
Oridonin Inhibits SARS‐CoV‐2 by Targeting Its 3C‐Like Protease
Baisen Zhong,Weiyu Peng,Shan Du,Bingyi Chen,Yajuan Feng,Xinfeng Hu,Qingying Lai,Shujie Liu,Zhong-Wei Zhou,Pengfei Wang,Yan Liang Xueqiong Wu,Feng Gao,Huihao Zhou,Litao Sun +13 more
TL;DR: It is demonstrated that Oridonin targets the SARS‐CoV‐2 3CL protease by covalently binding to cysteine145 in its active pocket to exert an anti‐SARS‐ CoV‐ 2 effect, which provides a novel candidate for the treatment of COVID‐19.
Journal ArticleDOI
Discovery of a small‐molecule inhibitor targeting the ovarian tumor domain of a novel Tamdy orthonairoviruse associated with human febrile illness
Zan Li,Weijia Wang,Shan Du,Zhuohang Chen,Bing Lim,Zhongwei Zhou,Kuancheng Liu,Feng Gao,Litao Sun +8 more
TL;DR: The results showed OTU domain of TcTV‐1 has a robust deubiquitinating activity and mecobalamin or its derivatives might be promising candidates for the treatment or prevention of disease caused by the Tc TV‐1 virus.